NueroMetrix Inc. (NASDAQ:NURO) shares soared almost 240% today towards a two-year high on record volume. The medical device company announced its Quell transcutaneous nerve stimulator received a ‘breakthrough device designation’ from the U.S Food and Drug Administration (FDA). The stock totaled up to a 700% increase within the last 2 days and volume spiked, making it the biggest gainer on the major U.S exchanges. ****** Watch our Live Trading show, Monday to Friday from 8:30am to 11:00am ET! https://www.youtube.com/tradertvlive
Trading Software: https://daytradetheworld.com/trading-software/
Legal Notice: The views and opinions expressed on TraderTV.Live are provided for information purposes only and should NOT be taken as (a) a solicitation of an offer to buy or sell a security, (b) an endorsement or recommendation of any particular security or trading strategy, or (c) investment advice.
The trading activity shown on TraderTV.Live are, stocks, futures and Forex purchases and sales, using real money and real-time market data. Our traders may own the securities they are trading on TraderTV.Live in their personal portfolios.
BEFORE MAKING ANY INVESTMENT DECISION, IT IS STRONGLY RECOMMENDED YOU SEEK ADVICE FROM A QUALIFIED BROKER OR INVESTMENT ADVISOR.
TRADERTV.LIVE DOES NOT PROVIDE OR GUARANTEE ANY FINANCIAL, LEGAL, TAX, OR ACCOUNTING ADVICE OR ADVICE REGARDING THE SUITABILITY, PROFITABILITY, OR POTENTIAL VALUE OF ANY PARTICULAR SECURITY, TRADING STRATEGY, OR INFORMATION SOURCE.
All content appearing on TraderTV.Live is protected by copyright law. Rebroadcasting or any other commercialized use of our program content is strictly prohibited.